VERITION FUND MANAGEMENT
Verition Fund Management operates as a multi-strategy and multi-manager investment platform. It has assembled a team of experienced, hard-to-access portfolio managers who draw their expertise from both proprietary trading desks and managing client accounts. The firm was founded in 2008 and is headquartered in
VERITION FUND MANAGEMENT
Industry:
Business Development Finance Financial Services
Founded:
2008-01-01
Status:
Active
Contact:
203 742 7700
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache Mobile Non Scaleable Content Euro DigiCert SSL CloudFront Typekit Visa Thawte SSL
Similar Organizations
Elevate Capital
Elevate Capital is a seed and early-stage investment firm with a focus in the Pacific Northwest and investing in under-represented founders.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-05 | Korro Bio | Verition Fund Management investment in Series B - Korro Bio | 116 M USD |
| 2021-10-04 | BYJU’S | Verition Fund Management investment in Series F - BYJU’S | 27 B INR |
| 2021-09-13 | Alebund Pharmaceuticals | Verition Fund Management investment in Series B - Alebund Pharmaceuticals | 54.5 M USD |
| 2021-09-09 | LEXEO Therapeutics | Verition Fund Management investment in Series B - LEXEO Therapeutics | 100 M USD |
| 2021-07-21 | Vedanta Biosciences | Verition Fund Management investment in Series D - Vedanta Biosciences | 43 M USD |
| 2021-07-20 | Amylyx Pharmaceuticals | Verition Fund Management investment in Series C - Amylyx Pharmaceuticals | 135 M USD |
| 2021-05-21 | Larimar Therapeutics | Verition Fund Management investment in Post-IPO Equity - Larimar Therapeutics | 95 M USD |
| 2021-04-15 | Biosplice Therapeutics | Verition Fund Management investment in Venture Round - Biosplice Therapeutics | 120 M USD |
| 2021-04-12 | GH Research | Verition Fund Management investment in Series B - GH Research | 125 M USD |
| 2020-07-28 | Praxis Precision Medicines | Verition Fund Management investment in Series C - Praxis Precision Medicines | 110 M USD |